| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | SENTI BIOSCIENCES INC CMN | Aug 6, 2025 | |
| Buy | SENTI BIOSCIENCES INC CMN | Aug 4, 2025 | |
| Buy | SENTI BIOSCIENCES INC CMN | Aug 1, 2025 | |
| Buy | SENGATA TECHNOLOGIES HOLDING | Jun 26, 2025 | |
| Sell | SENSATA TECHNOLOGIES | May 19, 2025 | |
| Buy | SENSATA TECHNOLOGIES HOLDING | Aug 1, 2023 |
This page tracks congressional stock trading activity in Senti Biosciences, Inc. (SNTI) in the Healthcare sector. Disclosed Capitol has indexed 6 disclosed congressional trades involving SNTI. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of September 2025 — Disclosed Capitol has tracked 6 disclosed congressional trades in Senti Biosciences, Inc. (SNTI) — 4:1 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Aug 6, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Aug 4, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Aug 1, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jun 26, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| May 19, 2025 | Michael McCaul | R | Exchange | $15,001 - $50,000 |
| Aug 1, 2023 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
Across the 6 disclosed congressional trades in Senti Biosciences, Inc. (SNTI), members of Congress have reported 4 buys and 1 sell. The average 30-day alpha vs. the S&P 500 is -21.18%.
For fiscal year 2025, Senti Biosciences, Inc. reported revenue of $22K and net income of -$61.4M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $33K, net income -$17.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.